Vietnam Investment Review on MSN
GenEditBio gets FDA clearance for in vivo genome editing programme
The clearance allows human trials for its one-time treatment targeting a genetic eye disease that causes vision loss.
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
Dr. Linda Genen named CMO to further strengthen GeneDx’s commitment to delivering earlier answers and better outcomes through ...
AZoLifeSciences on MSN
LINE-1 retrotransposons reshape cancer genome architecture
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
January 5, 2026) Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the ...
Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...
News-Medical.Net on MSN
Jumping genes reshape cancer genomes through 3D chromatin interactions
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE-1 in shaping the cancer genome structure and regulation.
7hon MSN
Brazil's genetic treasure trove: Supercentenarians reveal secrets of extreme human longevity
A Viewpoint published in Genomic Psychiatry by Dr. Mayana Zatz and colleagues at the Human Genome and Stem Cell Research ...
It’s Tuesday, Jan. 6, 2026, and today’s FSN Daily shifts from big-picture outlooks to the systems and science shaping food ...
A reduced genome in an island species raises evolutionary questions.
For quota_Anchor, collinear gene pairs are initially identified by a dynamic programming algorithm analogous to those implemented in DAGchainer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback